These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 10440620

  • 1. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
    Lipsky BA, Unowsky J, Zhang H, Townsend L, Talbot GH.
    Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
    [Abstract] [Full Text] [Related]

  • 2. Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia.
    Ramirez J, Unowsky J, Talbot GH, Zhang H, Townsend L.
    Clin Ther; 1999 Jan; 21(1):103-17. PubMed ID: 10090428
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M, Notario G, Spiller J, Palmer R, Busman T.
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [Abstract] [Full Text] [Related]

  • 4. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P, Dobryniewska M, Busman T, Notario G.
    Curr Med Res Opin; 2003 Feb; 19(5):411-20. PubMed ID: 13678478
    [Abstract] [Full Text] [Related]

  • 5. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D.
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [Abstract] [Full Text] [Related]

  • 6. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
    Lipsky BA, Miller B, Schwartz R, Henry DC, Nolan T, McCabe A, Magner DJ, Talbot GH.
    Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
    [Abstract] [Full Text] [Related]

  • 7. Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.
    Lipsky BA, Dorr MB, Magner DJ, Talbot GH.
    Clin Ther; 1999 Jan; 21(1):148-59. PubMed ID: 10090432
    [Abstract] [Full Text] [Related]

  • 8. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot GH.
    Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
    [Abstract] [Full Text] [Related]

  • 9. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis.
    Adelglass J, Jones TM, Ruoff G, Kahn JB, Wiesinger BA, Rielly-Gauvin K, Siu CO.
    Pharmacotherapy; 1998 Jul; 18(6):1255-63. PubMed ID: 9855324
    [Abstract] [Full Text] [Related]

  • 10. Sparfloxacin: a review.
    Schentag JJ.
    Clin Ther; 2000 Apr; 22(4):372-87; discussion 371. PubMed ID: 10823360
    [Abstract] [Full Text] [Related]

  • 11. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Zuck P, Vogel F, McIvor A, Peirzchala W, Smakal M, Staley H, Marr C.
    J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
    [Abstract] [Full Text] [Related]

  • 12. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M, Busman TA, Norris S, Notario GF.
    Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
    [Abstract] [Full Text] [Related]

  • 13. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
    Wilson R, Schentag JJ, Ball P, Mandell L, 068 Study Group.
    Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408
    [Abstract] [Full Text] [Related]

  • 14. Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group.
    Henry DC, Moller DJ, Adelglass J, Scheld WM, Jablonski CK, Zhang H, Talbot GH.
    Clin Ther; 1999 Feb; 21(2):340-52. PubMed ID: 10211537
    [Abstract] [Full Text] [Related]

  • 15. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S, DeAbate CA, Haverstock D, Aneiro L, Church D.
    Respir Med; 2000 Jan; 94(1):18-27. PubMed ID: 10714475
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ.
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S, Schreurs A, Siami G, Barkman HW, Anzueto A, Shan M, Moesker H, Stack T, Kowalsky S.
    Clin Infect Dis; 1998 Oct; 27(4):730-8. PubMed ID: 9798025
    [Abstract] [Full Text] [Related]

  • 18. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
    Henry DC, Nenad RC, Iravani A, Tice AD, Mansfield DL, Magner DJ, Dorr MB, Talbot GH.
    Clin Ther; 1999 Jun; 21(6):966-81. PubMed ID: 10440621
    [Abstract] [Full Text] [Related]

  • 19. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
    Weiss LR.
    Clin Ther; 2002 Sep; 24(9):1414-25. PubMed ID: 12380633
    [Abstract] [Full Text] [Related]

  • 20. A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
    Sokol WN, Sullivan JG, Acampora MD, Busman TA, Notario GF.
    Clin Ther; 2002 Apr; 24(4):605-15. PubMed ID: 12017405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.